These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 1356621)
1. Increased inosine-5'-phosphate dehydrogenase gene expression in solid tumor tissues and tumor cell lines. Collart FR; Chubb CB; Mirkin BL; Huberman E Cancer Res; 1992 Oct; 52(20):5826-8. PubMed ID: 1356621 [TBL] [Abstract][Full Text] [Related]
2. Regulation and role of inosine-5'-monophosphate dehydrogenase in cell replication, malignant transformation, and differentiation. Huberman E; Glesne D; Collart F Adv Exp Med Biol; 1994; 370():741-6. PubMed ID: 7661012 [No Abstract] [Full Text] [Related]
3. Inosine-5'-monophosphate dehydrogenase: regulation of expression and role in cellular proliferation and T lymphocyte activation. Zimmermann AG; Gu JJ; Laliberté J; Mitchell BS Prog Nucleic Acid Res Mol Biol; 1998; 61():181-209. PubMed ID: 9752721 [TBL] [Abstract][Full Text] [Related]
4. Expression of human IMP dehydrogenase types I and II in Escherichia coli and distribution in human normal lymphocytes and leukemic cell lines. Konno Y; Natsumeda Y; Nagai M; Yamaji Y; Ohno S; Suzuki K; Weber G J Biol Chem; 1991 Jan; 266(1):506-9. PubMed ID: 1670768 [TBL] [Abstract][Full Text] [Related]
5. Comparison of bax, waf1, and IMP dehydrogenase regulation in response to wild-type p53 expression under normal growth conditions. Liu Y; Riley LB; Bohn SA; Boice JA; Stadler PB; Sherley JL J Cell Physiol; 1998 Nov; 177(2):364-76. PubMed ID: 9766533 [TBL] [Abstract][Full Text] [Related]
6. Induction of Tmolt4 leukemia cell death by 3,3-disubstituted-6,6-pentamethylene-1,5-diazabicyclo[3.1.0]hexane-2-4-diones: specificity for type II inosine 5'-monophasphate dehydrogenase. Barnes BJ; Izydore RA; Eakin AE; Hall IH J Pharmacol Exp Ther; 2001 Aug; 298(2):790-6. PubMed ID: 11454943 [TBL] [Abstract][Full Text] [Related]
8. Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes. Jain J; Almquist SJ; Ford PJ; Shlyakhter D; Wang Y; Nimmesgern E; Germann UA Biochem Pharmacol; 2004 Feb; 67(4):767-76. PubMed ID: 14757177 [TBL] [Abstract][Full Text] [Related]
9. Proliferation-linked regulation of type II IMP dehydrogenase gene in human normal lymphocytes and HL-60 leukemic cells. Nagai M; Natsumeda Y; Weber G Cancer Res; 1992 Jan; 52(2):258-61. PubMed ID: 1345808 [TBL] [Abstract][Full Text] [Related]
10. Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part II. In vitro studies. Wright DG; Boosalis M; Malek K; Waraska K Leuk Res; 2004 Nov; 28(11):1137-43. PubMed ID: 15380336 [TBL] [Abstract][Full Text] [Related]
11. Analysis of differential protein expression in normal and neoplastic human breast epithelial cell lines. Williams K; Chubb C; Huberman E; Giometti CS Electrophoresis; 1998 Feb; 19(2):333-43. PubMed ID: 9548300 [TBL] [Abstract][Full Text] [Related]
12. Regulation of the human inosine monophosphate dehydrogenase type I gene. Utilization of alternative promoters. Gu JJ; Spychala J; Mitchell BS J Biol Chem; 1997 Feb; 272(7):4458-66. PubMed ID: 9020170 [TBL] [Abstract][Full Text] [Related]
13. Cloning and sequence of the human type II IMP dehydrogenase gene. Glesne DA; Huberman E Biochem Biophys Res Commun; 1994 Nov; 205(1):537-44. PubMed ID: 7999076 [TBL] [Abstract][Full Text] [Related]
14. Effects of human T lymphocyte activation on inosine monophosphate dehydrogenase expression. Dayton JS; Lindsten T; Thompson CB; Mitchell BS J Immunol; 1994 Feb; 152(3):984-91. PubMed ID: 7905505 [TBL] [Abstract][Full Text] [Related]
15. Gene amplification and dual point mutations of mouse IMP dehydrogenase associated with cellular resistance to mycophenolic acid. Lightfoot T; Snyder FF Biochim Biophys Acta; 1994 Mar; 1217(2):156-62. PubMed ID: 7906545 [TBL] [Abstract][Full Text] [Related]
16. IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma. Kofuji S; Hirayama A; Eberhardt AO; Kawaguchi R; Sugiura Y; Sampetrean O; Ikeda Y; Warren M; Sakamoto N; Kitahara S; Yoshino H; Yamashita D; Sumita K; Wolfe K; Lange L; Ikeda S; Shimada H; Minami N; Malhotra A; Morioka S; Ban Y; Asano M; Flanary VL; Ramkissoon A; Chow LML; Kiyokawa J; Mashimo T; Lucey G; Mareninov S; Ozawa T; Onishi N; Okumura K; Terakawa J; Daikoku T; Wise-Draper T; Majd N; Kofuji K; Sasaki M; Mori M; Kanemura Y; Smith EP; Anastasiou D; Wakimoto H; Holland EC; Yong WH; Horbinski C; Nakano I; DeBerardinis RJ; Bachoo RM; Mischel PS; Yasui W; Suematsu M; Saya H; Soga T; Grummt I; Bierhoff H; Sasaki AT Nat Cell Biol; 2019 Aug; 21(8):1003-1014. PubMed ID: 31371825 [TBL] [Abstract][Full Text] [Related]
17. Inosine-5'-monophosphate dehydrogenase is a rate-determining factor for p53-dependent growth regulation. Liu Y; Bohn SA; Sherley JL Mol Biol Cell; 1998 Jan; 9(1):15-28. PubMed ID: 9436988 [TBL] [Abstract][Full Text] [Related]
18. Inosine monophosphate dehydrogenase expression: transcriptional regulation of the type I and type II genes. Zimmermann A; Gu JJ; Spychala J; Mitchell BS Adv Enzyme Regul; 1996; 36():75-84. PubMed ID: 8869741 [TBL] [Abstract][Full Text] [Related]
19. Inosine 5'-monophosphate dehydrogenase as a chemotherapeutic target. Franklin TJ; Edwards G; Hedge P Adv Exp Med Biol; 1994; 370():155-60. PubMed ID: 7660881 [No Abstract] [Full Text] [Related]
20. Enzyme-pattern-targeted chemotherapy with tiazofurin and allopurinol in human leukemia. Weber G; Jayaram HN; Lapis E; Natsumeda Y; Yamada Y; Yamaji Y; Tricot GJ; Hoffman R Adv Enzyme Regul; 1988; 27():405-33. PubMed ID: 2907968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]